Gene therapy to avoid development of cardiomyopathy

14 April 2023 (12:09 - 12:21)

Organised by:

Video

Sign in for access options

Slides

About the speaker

Doctor Francesca Stillitano

University Medical Center Utrecht, Utrecht (Netherlands (The))

4 More presentations in this session

Presentation thumbnail

Polygenic risk scores for preventing cardiometabolic disease: are we there yet?

Professor M. Kavousi (Rotterdam, NL)

Presentation thumbnail

Young sudden cardiac death: an interplay of genetic, lifestyle and environmental factors

Doctor P. Chockalingam (Chennai, IN)

Presentation thumbnail

Are athletes made or born?: gene/environmental interaction may provide the answer

Professor A. La Gerche (Melbourne, AU)

Presentation thumbnail

Discussion – How genes and the environment interact to shape individual CV risk

Access the full session

Session thumbnail

How genes and the environment interact to shape individual CV risk

The Event

Event poster

ESC Preventive Cardiology 2023

14 April 2023 12:09 CET

You may be interested in

Congress Presentation

Gene editing to correct monogenic cardiomyopathies

31 August 2024

Congress Presentation

Knockdown of phospholamban using antisense oligonucleotides halts disease progression and resolves protein aggregation in mice with advanced phospholamban p.Arg14del cardiomyopathy

22 May 2022

Congress Presentation

Gene therapies for inherited channelopathies

31 August 2024

Congress Presentation

Gene editing for Danon disease

31 August 2025

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources